U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals

Continue Reading

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on ImmunoCellular and Nektar

Continue Reading

Natural Gas Prices Surging in 2013 Due to Warm Weather and Falling Supplies

Five Star Equities Provides Stock Research on Quicksilver Resources and Cheniere Energy

Continue Reading

U.S. Oil Refiners Battle Lower Margins Due to Rising Renewable Fuel Credits

RDInvesting Provides Stock Research on Alon USA Energy and PBF Energy

Continue Reading

Retail Industry Showing Strength in 2013 as Commerce Department Reports 1.1% Increase in February Sales

Five Star Equities Provides Stock Research on Foot Locker and Zumiez

Continue Reading

Refiners Battle Sharp Increase in Renewable Fuel Credits in 2013

RDInvesting Provides Stock Research on Delek US Holdings and Murphy Oil

Continue Reading

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on ArQule and Vanda Pharmaceuticals

Continue Reading

China and the United Kingdom Expected to Be Major Importers of Coal in 2013

RDInvesting Provides Stock Research on Natural Resource Partners and Walter Energy

Continue Reading

Long-Term Demand for Uranium to Be Driven by Emerging Nation – Miners Could Receive Boost From End of Russia-s Disarmament Treaty

Five Star Equities Provides Stock Research on Uranium Energy and Uranium Resources

Continue Reading

United Kingdom Coal Imports Expected to Rise Sharply After Closure of Two Major Mines

RDInvesting Provides Stock Research on Cloud Peak Energy and CONSOL Energy

Continue Reading